The main pharmacological characteristics of Grandaxin (tofizopam, EGYT-341).
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001522:Behavior, Animal / Q000187:drug effects; D001569:Benzodiazepines; D002415:Cats; D006224:Cricetinae; D004285:Dogs; D004347:Drug Interactions; D051379:Mice; D051381:Rats
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines